Show simple item record

dc.contributor.authorAsadi, N
dc.contributor.authorAnnabi, N
dc.contributor.authorMostafavi, E
dc.contributor.authorAnzabi, M
dc.contributor.authorKhalilov, R
dc.contributor.authorSaghfi, S
dc.contributor.authorMehrizadeh, M
dc.contributor.authorAkbarzadeh, A
dc.date.accessioned2018-08-26T09:37:28Z
dc.date.available2018-08-26T09:37:28Z
dc.date.issued2018
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/58106
dc.description.abstractMagnetic nanoparticles have properties that cause to apply them in cancer therapy and vehicles for the delivery of drugs such as 5FU, especially when they are modified with biocompatible copolymers. The aim of this study is to modify superparamagnetic iron oxide nanoparticles (SPIONPs) with PCL-PEG-PCL copolymers and then utilization of these nanoparticles for encapsulation of anticancer drug 5FU. The ring-opening polymerization (ROP) was used for the synthesis of PCL-PEG-PCL copolymer by ?-caprolactone (PCL) and polyethylene glycol (PEG2000). We used the double emulsion method (water/oil/water) to prepare 5FU-encapsulated Fe3O4 magnetic nanoparticles modified with PCL-PEG-PCL copolymer. Chemical structure and magnetic properties of 5FU-loaded magnetic-polymer nanoparticles were investigated systematically by employing FT-IR, XRD, VSM and SEM techniques. In vitro release profile of 5FU-loaded NPs was also determined. The results showed that the encapsulation efficiency value for nanoparticles were 90%. Moreover, the release of 5FU is significantly higher at pH 5.8 compared to pH 7.4. Therefore, these nanoparticles have sustained release and can apply for cancer therapy. © 2018 Informa UK Limited, trading as Taylor & Francis Group
dc.language.isoEnglish
dc.relation.ispartofArtificial Cells, Nanomedicine and Biotechnology
dc.subjectBiocompatibility
dc.subjectDiseases
dc.subjectDrug delivery
dc.subjectEmulsification
dc.subjectEncapsulation
dc.subjectIron oxides
dc.subjectMagnetic levitation vehicles
dc.subjectMagnetism
dc.subjectNanomagnetics
dc.subjectNanoparticles
dc.subjectOncology
dc.subjectPolyethylene glycols
dc.subjectPolyethylene oxides
dc.subjectRing opening polymerization
dc.subjectSynthesis (chemical)
dc.subjectTargeted drug delivery
dc.subjectControlled delivery
dc.subjectDouble emulsions
dc.subjectEncapsulation efficiency
dc.subjectIn-vitro evaluation
dc.subjectMagnetic nano-particles
dc.subjectMagnetic polymers
dc.subjectSuperparamagnetic iron oxide nanoparticles
dc.subjectSustained release
dc.subjectControlled drug delivery
dc.titleSynthesis, characterization and in vitro evaluation of magnetic nanoparticles modified with PCL-PEG-PCL for controlled delivery of 5FU
dc.typeReview
dc.citation.spage1
dc.citation.epage8
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.1080/21691401.2018.1439839


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record